A facile one-pot regioselective synthesis of functionalized novel benzo[f]chromeno[4,3-b][1,7]naphthyridines and benzo[f][1,7]naphthyridines via an imino Diels-Alder reaction
暂无分享,去创建一个
[1] S. Han,et al. Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents. , 2016, ACS medicinal chemistry letters.
[2] S. Han,et al. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB. , 2015, Bioorganic & medicinal chemistry letters.
[3] Heesoon Lee,et al. Novel NF-κB inhibitors: a patent review (2011 – 2014) , 2015, Expert opinion on therapeutic patents.
[4] L. Fu,et al. Efficient synthesis and evaluation of antitumor activities of novel functionalized 1,8-naphthyridine derivatives. , 2015, ACS combinatorial science.
[5] B. Pfeiffer,et al. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine. , 2014, Journal of medicinal chemistry.
[6] M. Lahtela-Kakkonen,et al. Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells. , 2014, Journal of medicinal chemistry.
[7] R. Pratap,et al. Natural and synthetic chromenes, fused chromenes, and versatility of dihydrobenzo[h]chromenes in organic synthesis. , 2014, Chemical reviews.
[8] S. Han,et al. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors. , 2014, Bioorganic & medicinal chemistry letters.
[9] W. Cho,et al. Topoisomerase inhibitors as anticancer agents: a patent update , 2013, Expert opinion on therapeutic patents.
[10] Jun Xu,et al. First total synthesis and determination of the absolute configuration of 1-N-methyl-3-methylamino-[N-butanoicacid-3-(9-methyl-8-propen-7-one)-amide]-benzo[f][1,7]naphthyridine-2-one, a novel benzonaphthyridine alkaloid , 2012 .
[11] Y. Pommier,et al. Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation. , 2012, The Journal of organic chemistry.
[12] G. Rummel,et al. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. , 2011, Bioorganic & medicinal chemistry letters.
[13] Zhenyuan Miao,et al. New strategies in the discovery of novel non-camptothecin topoisomerase I inhibitors. , 2011, Current medicinal chemistry.
[14] Malgorzata N. Drwal,et al. Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents , 2011, PloS one.
[15] Adam Siddiqui-Jain,et al. Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. , 2011, Journal of medicinal chemistry.
[16] Y. Pommier,et al. Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents. , 2010, Journal of medicinal chemistry.
[17] J. Hong,et al. Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives. , 2010, Bioorganic & medicinal chemistry letters.
[18] R. Nagarajan,et al. CuI/La(OTf)3 catalyzed, one-pot synthesis of isomeric ellipticine derivatives in ionic liquid , 2010 .
[19] S. Hotha,et al. Orthogonal activation of propargyl and n-pentenyl glycosides and 1,2-orthoesters. , 2009, The Journal of organic chemistry.
[20] T. P. Lebold,et al. Stereodivergent synthesis of fused bicyclopyrazolidines: access to pyrazolines and pyrrolidines. , 2009, Organic letters.
[21] S. Desrat,et al. Intramolecular imino Diels-Alder reaction: progress toward the synthesis of uncialamycin. , 2009, The Journal of organic chemistry.
[22] S. Matsunaga,et al. A heterobimetallic Ga/Yb-Schiff base complex for catalytic asymmetric alpha-addition of isocyanides to aldehydes. , 2009, Journal of the American Chemical Society.
[23] Y. Pommier,et al. The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives , 2009, Molecular Cancer Therapeutics.
[24] S. Genovese,et al. Preparation of Triaryl-and Triheteroarylmethanes under Ytterbium Triflate Catalysis and Solvent-Free Conditions , 2009 .
[25] Jie Wu,et al. Tandem cyclization-[3+3] cycloaddition reactions of 2-alkynylbenzaldoxime: synthesis of fused 1,2-dihydroisoquinolines , 2009 .
[26] Weidong Rao,et al. Ytterbium(III) triflate-catalyzed amination of 1-cyclopropylprop-2-yn-1-ols as an expedient route to conjugated enynes. , 2009, The Journal of organic chemistry.
[27] D. Hazuda,et al. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. , 2008, Bioorganic & medicinal chemistry letters.
[28] K. Sharpless,et al. Mechanistic studies on the Cu-catalyzed three-component reactions of sulfonyl azides, 1-alkynes and amines, alcohols, or water: dichotomy via a common pathway. , 2008, The Journal of organic chemistry.
[29] Yuehong Wang,et al. Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds. , 2008, Journal of combinatorial chemistry.
[30] W. Su,et al. Yb(OTf)3 catalyzed condensation reaction of β-naphthol and aldehyde in ionic liquids: a green synthesis of aryl-14H-dibenzo[a,j]xanthenes , 2008 .
[31] Xigeng Zhou,et al. Direct Substitution of the Hydroxy Group at the Allylic/propargylic Position with Carbon- and Heteroatom- centered Nucleophiles Catalyzed by Yb(OTf)3 , 2008 .
[32] B. Hwang,et al. Synthesis of chroman-2-carboxylic acid N-(substituted)phenylamides and their inhibitory effect on nuclear factor-κB (NF-κB) activation , 2008 .
[33] A. Fürstner,et al. Two manifolds for metal-catalyzed intramolecular diels-alder reactions of unactivated alkynes. , 2007, Angewandte Chemie.
[34] Byung Hak Kim,et al. Structure-activity relationships of 6-hydroxy-7-methoxychroman-2-carboxylic acid N-(substituted)phenylamides as inhibitors of nuclear factor-kB activation , 2007 .
[35] Y. Pommier,et al. Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization. , 2007, Journal of medicinal chemistry.
[36] Yves Pommier,et al. Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors. , 2007, Journal of medicinal chemistry.
[37] Le‐Ping Liu,et al. Lewis acid-catalyzed reactions of mono-aryl group substituted methylenecyclopropanes with diethyl ketomalonate , 2007 .
[38] R. Nagarajan,et al. A new entry to polycyclic indole derivatives via intramolecular imino Diels-Alder reaction: observation of unexpected reaction. , 2007, The Journal of organic chemistry.
[39] Y. Yun,et al. Oleanolic acid, a pentacyclic triterpenoid, induces rabbit platelet aggregation through a phospholipase C-calcium dependent signaling pathway , 2007, Archives of pharmacal research.
[40] Y. Pommier. Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.
[41] B. Harrison,et al. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity. , 2006, Journal of medicinal chemistry.
[42] W. Su,et al. A Facile Synthesis of 1-Substituted-1H-1,2,3,4-Tetrazoles Catalyzed by Ytterbium Triflate Hydrate , 2006 .
[43] Lili Lin,et al. A mild and efficient aza-Diels–Alder reaction of N-benzhydryl imines with trans-1-methoxy-2-methyl-3-trimethylsiloxybuta-1,3-diene catalyzed by Yb(OTf)3 , 2005 .
[44] L. Strekowski,,et al. New triple-helix DNA stabilizing agents. , 2005, Bioorganic & medicinal chemistry letters.
[45] F. Himo,et al. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. , 2004, Journal of the American Chemical Society.
[46] H. Tian,et al. A Convenient Synthesis of α,α′-Bis(substituted benzylidene)cycloalkanones Catalyzed by Yb(OTf)3 Under Solvent-Free Conditions , 2004 .
[47] M. Crul. CKD-602. Chong Kun Dang. , 2003, Current opinion in investigational drugs.
[48] W. Denny,et al. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines. , 2003, Journal of medicinal chemistry.
[49] Y. Pommier,et al. Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors. , 2000, Journal of medicinal chemistry.
[50] Yao,et al. Catalytic enantioselective aza-Diels-alder reactions of imines--an approach to optically active nonproteinogenic alpha-amino acids , 2000, Chemistry.
[51] S. Mackay,et al. Synthesis of Dibenzo[c,h][1,6]naphthyridine, [2]Benzopyrano[4,3-c]quinoline and Benzo[i]phenanthridine Analogues of the Quaternary Benzo[c]phenanthridines , 2000 .
[52] V. D. Dyachenko,et al. Naphthyridines. Structure, physicochemical properties and general methods of synthesis , 2000 .
[53] B. Lohray,et al. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives. , 1999, Journal of medicinal chemistry.
[54] L. Chan,et al. Discovery of 1,6-naphthyridines as a novel class of potent and selective human cytomegalovirus inhibitors. , 1999, Journal of medicinal chemistry.
[55] K. Kusakabe,et al. A SWITCH OF ENANTIOFACIAL SELECTIVITIES USING DESIGNED SIMILAR CHIRAL LIGANDS IN ZIRCONIUM-CATALYZED ASYMMETRIC AZA DIELS-ALDER REACTIONS , 1999 .
[56] S. Kobayashi. Scandium Triflate in Organic Synthesis , 1999 .
[57] Y. Pommier,et al. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. , 1999, Journal of medicinal chemistry.
[58] M. Johannsen,et al. Catalytic Enantioselective Aza Diels-Alder Reactions of Imino Dienophiles. , 1998, Angewandte Chemie.
[59] S. Bromidge,et al. A parallel combinatorial approach to locating homochiral Lewis acid catalysts for the asymmetric aza-Diels-Alder reaction of an imino dienophile , 1998 .
[60] R. N. Brogden,et al. Topotecan. A review of its potential in advanced ovarian cancer. , 1998, Drugs.
[61] H. Audrain,et al. Catalytic Asymmetric Hetero-Diels−Alder Reactions of Ketones: Chemzymatic Reactions , 1998 .
[62] H. Ishitani,et al. The First Enantioselective Aza-Diels-Alder Reactions of Imino Dienophiles on Use of a Chiral Zirconium Catalyst. , 1998, Angewandte Chemie.
[63] Marvin J. Miller,et al. DEVELOPMENT AND APPLICATIONS OF AMINO ACID-DERIVED CHIRAL ACYLNITROSO HETERO DIELS-ALDER REACTIONS , 1998 .
[64] Y. Tsuchida,et al. Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice. , 1998, Cancer letters.
[65] P. Zarantonello,et al. Synthesis and Use of N-(Trimethylsilyl)imines , 1998 .
[66] Lutz F. Tietze,et al. HETERO DIELS-ALDER REACTIONS IN ORGANIC CHEMISTRY , 1997 .
[67] Kiho Lee,et al. Synthesis and antitumor activity of 7-substituted 20(RS)-camptothecin analogues , 1996 .
[68] H. Waldmann. AMINO-ACID ESTERS - VERSATILE CHIRAL AUXILIARY GROUPS FOR THE ASYMMETRIC-SYNTHESIS OF NITROGEN-HETEROCYCLES , 1995 .
[69] D. Emerson,et al. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. , 1995, Cancer research.
[70] H. Waldmann. Asymmetric Hetero Diels-Alder Reactions , 1994 .
[71] D. Boger,et al. Hetero Diels-Alder methodology in organic synthesis , 1987 .
[72] S. Weinreb. Alkaloid total synthesis by intramolecular imino Diels-Alder cycloadditions , 1985 .
[73] D. Boger. Diels-Alder reactions of azadienes , 1983 .
[74] S. Weinreb,et al. Stereochemistry of the intramolecular imino Diels-Alder reaction , 1980 .
[75] E. Corey,et al. Stereo-controlled synthesis of dl-prostaglandins F2.alpha. and E2 , 1969 .
[76] L. S. Povarov. αβ-UNSATURATED ETHERS AND THEIR ANALOGUES IN REACTIONS OF DIENE SYNTHESIS , 1967 .
[77] A. McPhail,et al. Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .